B
Bull
Bull · 25%OSCR
$20.09
Scenario price
$31.890
-1.505 (-4.72%)At close
Loading chart…
- High
- 33.505
- Open
- 33.380
- VWAP
- 32.35
- Volume
- 5.75M
- Mkt Cap
- 4.19B
- Low
- 31.650
- Amount
- 186.16M
- EV/EBITDA, TTM
- 4.13
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces.
AI analysis of Oscar Health Inc (OSCR)
BuyOscar Health Inc is a good buy right now due to its current price of $33.37, which is significantly below the analyst price target of $42 from Raymond James, indicating a potential upside of 25.5%. Additionally, the company has shown strong earnings growth with a reported EPS of 1.10, a 155.81% surprise over estimates, and a robust year-to-date change of +122.91%. However, the main risk is the forward P/E ratio of 588.24, which suggests that the stock may be overvalued if growth expectations are not met.
Valuation Metrics
The current forward P/E ratio for Oscar Health Inc (OSCR) is 588.24, compared to its 5-year average forward P/E of 123.87.
Alphio AI Price Scenarios for OSCR
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding OSCR
Events Timeline
News
9.510-12NewsfilterOscar Health to Release Q3 2026 Financial Results on November 5
2.009-30FoolInvestors Overlook Healthcare Sector Amid AI Focus
5.009-25FoolFour Overlooked Stocks with Doubling Potential
- 8.509-19Newsfilter
Oscar Health Share Distribution of 6.3 Million Shares by Thrive Capital
2.009-12Yahoo FinanceHealthcare Stocks Surge Amid Macroeconomic Uncertainty
OSCR FAQ — answered by Alphio AI
Oscar Health, Inc. is a healthcare technology company built around a full-stack technology platform. The Company serves individuals, families, and employees through the Patient Protection and Affordable Care Act (ACA). It also offers health technology solutions that power the healthcare industry through +Oscar. It also wholly owns three businesses operating in the individual market: Lucie, Inc., a technology enrollment platform for consumers, employers and brokers; Trove Group Inc., an insurance agency that sells individual medical and supplemental health products, and HealthInsurance.org, LLC, a lead generation website providing educational content to help consumers navigate health insurance as well as the ACA and Medicare marketplaces. It operates in the Financials sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Oscar Health Inc is a good buy right now due to its current price of $33.37, which is significantly below the analyst price target of $42 from Raymond James, indicating a potential upside of 25.5%. Additionally, the company has shown strong earnings growth with a reported EPS of 1.10, a 155.81% surprise over estimates, and a robust year-to-date change of +122.91%. However, the main risk is the forward P/E ratio of 588.24, which suggests that the stock may be overvalued if growth expectations are not met.
Community
More ↗
$oscr is finishing up a 5 year IPO base. In 2021 they did $1.84B in revenue. This year they will do 10X. You missed nothing. This is the beginning
Show more
$OSCR CMS has cracked down on unauthorized enrollments after tracking a surge in consumer complaints, analyzing statistically implausible application rates submitted by specific brokers, and reviewing accounts missing critical identifying information like Social Security numbers. They have canceled approximately 315,000 unauthorized enrollments covering more than 760,000 individuals, which is expected to result in a return of roughly $2.2B in taxpayer-funded subsidies. Oscar Health accounted for >250,000 of these enrollments!
Show more
$OSCR Management grew and sold Aethna to CVS and shareholders did great. Can there be a repeat? Sometimes they rhyme. If there is a solution for healthcare, OSCR might have the answers. Look at the base since the IPO. You haven't missed a thing. We might be at the point where the meat of the move begins ahead.
Show more
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.